Skip to main navigation Skip to search Skip to main content

Glycosylation of human fibrinogen in vivo

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Fibrinogen was purified from plasma from 22 non-diabetic and 26 poorly controlled Type 1 (insulin-dependent) diabetic subjects. In non-diabetic subjects, 0.95 +/- 0.17 mol glucose was bound per mol fibrinogen, whereas in the diabetic subjects 1.33 +/- 0.21 mol glucose was bound per mol fibrinogen (mean +/- SD, p less than 0.001). Comparison of the amount of bound glucose, when estimated by two different methods, suggested that lysine is the site of glycosylation. It is currently unknown whether this increased glycosylation of fibrinogen alters its function
Original languageEnglish
Pages (from-to)87-89
JournalDiabetologia
Volume28
Issue number2
Publication statusPublished - 1985

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Glycosylation of human fibrinogen in vivo'. Together they form a unique fingerprint.

Cite this